Digital Health Technologies to Improve Medication Adherence and Treatment Outcomes in Patients With Tuberculosis: Systematic Review of Randomized Controlled Trials.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Works matching AU Yalcin, Esin Aki
Results: 13
1
2
Synthesis, Antimicrobial Activities of New Sulfonamidobenzoxazoles and Molecular Docking Studies on Escherichia coli TEM-1 ß-Lactamase.
- Published in:
- Croatica Chemica Acta, 2017, v. 90, n. 1, p. 67, doi. 10.5562/cca3111
- By:
- Publication type:
- Article
3
Homology modeling in drug discovery: Overview, current applications, and future perspectives.
- Published in:
- Chemical Biology & Drug Design, 2019, v. 93, n. 1, p. 12, doi. 10.1111/cbdd.13388
- By:
- Publication type:
- Article
4
New human Glutathione-S-transferase P1-1 inhibitors and their ligand binding site and GSH complex formation descriptions.
- Published in:
- Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2016, v. 62, p. 571
- By:
- Publication type:
- Article
5
Docking studies of neurokinin-1 receptor antagonists as an anticancer target.
- Published in:
- Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2016, v. 62, p. 553
- By:
- Publication type:
- Article
6
Binding site description of 2-substituted benzothiazoles as potential RND efflux pump inhibitors.
- Published in:
- Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2016, v. 62, p. 543
- By:
- Publication type:
- Article
7
DNA topoisomerase inhibitory activity and 3D-QSAR analysis of benzazoles.
- Published in:
- Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2016, v. 62, p. 535
- By:
- Publication type:
- Article
8
Benzoxazines as new human topoisomerase I inhibitors and potential poisons.
- Published in:
- DARU: Journal of Pharmaceutical Sciences, 2019, v. 27, p. 65, doi. 10.1007/s40199-019-00315-x
- By:
- Publication type:
- Article
9
Biological evaluation and pharmacophore modeling of some benzoxazoles and their possible metabolites.
- Published in:
- Archiv der Pharmazie, 2018, v. 351, n. 2, p. 1, doi. 10.1002/ardp.201700265
- By:
- Publication type:
- Article
10
Design and synthesis of 2-substituted-5-(4-trifluoromethylphenyl-sulphonamido)benzoxazole derivatives as human GST P1-1 inhibitors.
- Published in:
- Artificial Cells, Nanomedicine & Biotechnology, 2018, v. 46, n. 3, p. 510, doi. 10.1080/21691401.2017.1324464
- By:
- Publication type:
- Article
11
Synthesis of novel carboxamide- and carbohydrazide-benzimidazoles as selective butyrylcholinesterase inhibitors.
- Published in:
- Molecular Diversity, 2022, v. 26, n. 5, p. 2863, doi. 10.1007/s11030-022-10476-8
- By:
- Publication type:
- Article
12
The 12<sup>th</sup> AFMC International Medicinal Chemistry Symposium (AIMECS 2019) in Istanbul, Turkey.
- Published in:
- ChemMedChem, 2020, v. 15, n. 1, p. 162, doi. 10.1002/cmdc.201900623
- By:
- Publication type:
- Article
13
Synthesis and Biological Evaluation of 2-Substituted-5-(4-nitrophenylsulfonamido)benzoxazoles as Human GST P1-1 Inhibitors, and Description of the Binding Site Features.
- Published in:
- ChemMedChem, 2014, v. 9, n. 5, p. 984, doi. 10.1002/cmdc.201400010
- By:
- Publication type:
- Article